What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Connexin, Cell biology, Gap junction, Gene and Pannexin.
His study explores the link between Connexin and topics such as Gating that cross with problems in Ion channel.
The study incorporates disciplines such as Xenopus and Cell junction in addition to Cell biology.
His biological study spans a wide range of topics, including Cytoplasm and Neuroscience, Neuron.
His research investigates the connection between Gene and topics such as Intracellular that intersect with problems in Cell, Phosphorylation and Tooth disease.
His study focuses on the intersection of Pannexin and fields such as Homomeric with connections in the field of Synapse.
His most cited work include:
- Connections with connexins: the molecular basis of direct intercellular signaling (1212 citations)
- First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. (672 citations)
- Pannexins, a family of gap junction proteins expressed in brain (606 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cell biology, Connexin, Gap junction, Virology and Internal medicine.
His Cell biology study incorporates themes from Protein subunit and Cellular differentiation.
In his work, Electrical Synapses and Pannexin is strongly intertwined with Neuroscience, which is a subfield of Connexin.
His Gap junction research integrates issues from Cell signaling, Cytoplasm, Xenopus, Cell junction and Molecular biology.
His Virology research includes themes of Antibody and Immune system.
Roberto Bruzzone works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Amylase and Bombesin.
He most often published in these fields:
- Cell biology (39.51%)
- Connexin (32.10%)
- Gap junction (30.25%)
What were the highlights of his more recent work (between 2011-2021)?
- Virology (31.48%)
- Antibody (11.73%)
- Immune system (12.35%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Virology, Antibody, Immune system, Cell biology and Antibody-dependent enhancement.
His research in Virology intersects with topics in Receptor and Polyclonal antibodies.
His work carried out in the field of Antibody brings together such families of science as Cercopithecus aethiops, Vero cell and Pathogenesis.
His study in Immune system is interdisciplinary in nature, drawing from both Cell cycle checkpoint, Cell cycle, Vaccination and Protein–protein interaction.
Cell biology is closely attributed to Genome in his study.
His Antibody-dependent enhancement study integrates concerns from other disciplines, such as Chlorocebus aethiops, Flavivirus, ADP ribosylation factor and Constitutive secretory pathway.
Between 2011 and 2021, his most popular works were:
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus (136 citations)
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus (136 citations)
- Randomised controlled trials for Ebola: practical and ethical issues (116 citations)
In his most recent research, the most cited papers focused on:
Roberto Bruzzone mainly investigates Virology, Antibody-dependent enhancement, Antibody, Immune system and Virus.
Roberto Bruzzone interconnects ADP ribosylation factor and Signal peptide in the investigation of issues within Virology.
His Antibody-dependent enhancement research incorporates elements of Viral life cycle, Flavivirus and Constitutive secretory pathway.
His Antibody research is multidisciplinary, relying on both Vero cell, Chlorocebus aethiops, Viral replication and Pathogenesis.
His Immune system research incorporates themes from Cell culture and Tropism.
Virus is a subfield of Immunology that Roberto Bruzzone investigates.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
